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Real-World Data (RWD) and Real-World Evidence (RWE) are playing an increasing role in health care decisions. 
This data holds the potential to allow us to better design and conduct studies in the health care setting. 
Randomized Controlled Trials (RCT) are time and resource-intensive, lack of generalizability and typically 
restricted to evaluating specific interventions one at a time.
Aim of the review
To assess the literature to establish a clearer definition of Real World Validation (RWV) including a better 
understanding of the associated methods, determining in how and in which contexts RWV has been used.
Background
Hypothesis / Definition
Real-World Validation is a cost-effective, and adaptable mix-method user inclusive methodology to
assess the impact and benefits to patients, staff and the health economy, in a non-controlled
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gs RCTs are being challenged by health care providers since they are looking for RWE to validate
innovative interventions.
RWV generates insight, foresight, and explorative findings to bring a product to the healthcare
market and to ensure its significance in clinical practice, grasping up with the principles of
health economics and outcome research, thereby exhibiting the value of real-world insights in
healthcare decision.
